Potential Value of miR-23a for Discriminating Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis

Wessam Sharaf-Eldin ¹ * , Nirmeen Kishk ², Basma Sakr ³, Hazem El-Hariri ⁴, Miral Refeat ¹, Nagham ElBagoury ¹, Mona Essawi ¹

Cited by CrossRef: 2

1- Lindblom J, Mohan C, Parodis I. Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade. Brain Sciences. 2022;12(2):192 [Crossref]

2- Muñoz-San Martín M, de la Guerra-Sasián L, Gárate G, Madera J, González-Suárez A, Cavada-Bustamante N, González-Quintanilla V, Dowling J. From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis. IJMS. 2025;26(17):8740 [Crossref]

3- Ding H, Shen Y, Hong S, Xiang C, Shen N. Biomarkers for systemic lupus erythematosus – a focus on organ damage. Expert Review of Clinical Immunology. 2024;20(1):39 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.